Kestra Medical Technologies (KMTS) Receivables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Receivables data on file, last reported at $12.7 million in Q1 2026.

• Receivables for Q1 2026 came in at $12.7 million, up 60.29% year-over-year; the trailing twelve-month figure through Jan 2026 was $12.7 million (up 60.29% YoY), and the FY2025 annual result was $8.1 million, up 304.45% from the prior year.
• Receivables advanced to $12.7 million in Q1 2026 per KMTS's latest filing, from $10.4 million in the prior quarter.
• Over five years, Receivables peaked at $12.7 million in Q1 2026 and troughed at $2.0 million in Q2 2024.
• A 3-year average of $8.4 million and a median of $8.7 million in 2025 frame the typical range for Receivables.
• The sharpest annual moves came in 2025 and 2026: Receivables jumped 304.45% in 2025, then surged 60.29% in 2026.
• A 3-year view of Receivables shows it stood at $2.0 million in 2024, then soared by 421.17% to $10.4 million in 2025, then grew by 22.05% to $12.7 million in 2026.
• Business Quant data shows KMTS's Receivables at $12.7 million in Q1 2026, $10.4 million in Q4 2025, and $9.2 million in Q3 2025.